SummaryObjective To investigate whether levels of endogenous hormones, in particular circulating oestrogens and SHBG, are associated with cognition in healthy postmenopausal women. Design Cross-sectional study. Patients Four hundred and two healthy postmenopausal women aged 50-74 years between 8 and 30 years after menopause, none taking oestrogen. Measurements Serum concentration of oestradiol, oestrone, and sex hormone binding globulin (SHBG) determined by immunoassay. Cognition assessed using the mini-mental state examination questionnaire (MMSE). Results In this group, 149 individuals had a MMSE score < 27, while only 89 individuals had a MMSE score < 26, indicating a relatively healthy population with regard to cognitive ability. Cognition decreased with age, time since menopause and blood pressure, and was better with higher age at menopause. Serum oestrogens and SHBG levels were not related to age, age at menopause, or time since menopause, and oestrogen levels were positively associated with blood pressure. After adjustment for mean arterial pressure and SHBG, the frequency of mild cognitive impairment decreased significantly with higher oestradiol and oestrone serum levels [ORs Q5 vs. Q1: 0·41 (95% CI 0·20 -0·84) and 0·51 (95% CI 0·20 -0·99) for oestradiol and oestrone, respectively]. Conclusions Postmenopausal women with higher remaining circulating oestradiol levels appear less likely to suffer from cognitive impairment. This effect is independent of age at menopause, time since menopause and BMI. These findings support the hypothesis that endogenous oestrogens may protect against cognitive decline with ageing. An increase of life expectancy is not necessarily accompanied by a similar increase in healthy life span, and understanding determinants of successful ageing and in particular the role played by endocrine factors has gained increased interest.1 Women are likely to live one third of their lives in a state of relative oestrogen deficiency, which is held responsible for unfavourable long-term effects on bone metabolism, the cardiovascular system, and probably cognitive function culminating in dementia. There is growing evidence that oestrogens impact on memory, affect, and motor co-ordination in women, and they also appear to have a neuroprotective effect for Alzheimer's disease. 2,3 In contrast, results from studies with hormonal replacement therapy (HRT) have not supported a protective effect of exogenous oestrogens on cognitive functions. 4-6 A few studies have addressed the role of the remaining circulating postmenopausal oestrogens in cognition, but were hampered by small sample sizes or improper adjustment for potential confounders. 7-10 Two studies reported protective effect of higher oestradiol levels on cognitive decline, 3,11 while a recent study found that higher serum oestradiol levels were associated with a higher risk of Alzheimer's disease.12